nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS2—Doxorubicin—sarcoma	0.185	0.266	CbGbCtD
Metformin—NDUFS3—Doxorubicin—sarcoma	0.185	0.266	CbGbCtD
Metformin—NDUFS7—Doxorubicin—sarcoma	0.185	0.266	CbGbCtD
Metformin—SLC47A1—Mitoxantrone—sarcoma	0.103	0.148	CbGbCtD
Metformin—SLC22A3—Vincristine—sarcoma	0.0369	0.0531	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—sarcoma	0.00374	1	CbGdCrCtD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—NPM1—sarcoma	0.00115	0.0841	CbGpPWpGaD
Metformin—NDUFV3—FOXA1 transcription factor network—COL18A1—sarcoma	0.000987	0.0722	CbGpPWpGaD
Metformin—NDUFV3—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.000732	0.0535	CbGpPWpGaD
Metformin—NDUFS2—p73 transcription factor network—WT1—sarcoma	0.000387	0.0283	CbGpPWpGaD
Metformin—NDUFB10—lymphoid tissue—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFAF1—tendon—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFA4L2—testis—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFB11—uterus—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFV1—uterus—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFB8—cardiac atrium—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFS5—cardiac atrium—sarcoma	0.000372	0.00186	CbGeAlD
Metformin—NDUFA10—bone marrow—sarcoma	0.00037	0.00185	CbGeAlD
Metformin—NDUFA12—lymphoid tissue—sarcoma	0.00037	0.00185	CbGeAlD
Metformin—NDUFS5—uterus—sarcoma	0.00037	0.00185	CbGeAlD
Metformin—NDUFB8—uterus—sarcoma	0.00037	0.00185	CbGeAlD
Metformin—NDUFB1—lymphoid tissue—sarcoma	0.000367	0.00184	CbGeAlD
Metformin—NDUFC1—bone marrow—sarcoma	0.000367	0.00183	CbGeAlD
Metformin—NDUFAF2—tendon—sarcoma	0.000366	0.00183	CbGeAlD
Metformin—NDUFB3—tendon—sarcoma	0.000366	0.00183	CbGeAlD
Metformin—NDUFS2—connective tissue—sarcoma	0.000366	0.00183	CbGeAlD
Metformin—NDUFB2—bone marrow—sarcoma	0.000364	0.00182	CbGeAlD
Metformin—NDUFA6—lymphoid tissue—sarcoma	0.000362	0.00181	CbGeAlD
Metformin—NDUFV2—liver—sarcoma	0.000362	0.00181	CbGeAlD
Metformin—NDUFS3—connective tissue—sarcoma	0.000361	0.00181	CbGeAlD
Metformin—NDUFAF1—bone marrow—sarcoma	0.000361	0.0018	CbGeAlD
Metformin—NDUFS4—lymphoid tissue—sarcoma	0.00036	0.0018	CbGeAlD
Metformin—NDUFA11—tendon—sarcoma	0.000358	0.00179	CbGeAlD
Metformin—ND6—bone marrow—sarcoma	0.000358	0.00179	CbGeAlD
Metformin—NDUFB4—lymphoid tissue—sarcoma	0.000355	0.00178	CbGeAlD
Metformin—NDUFAF4—tendon—sarcoma	0.000355	0.00178	CbGeAlD
Metformin—NDUFB6—tendon—sarcoma	0.000355	0.00178	CbGeAlD
Metformin—NDUFB3—bone marrow—sarcoma	0.000355	0.00177	CbGeAlD
Metformin—NDUFAF2—bone marrow—sarcoma	0.000355	0.00177	CbGeAlD
Metformin—NDUFAB1—lymphoid tissue—sarcoma	0.000353	0.00176	CbGeAlD
Metformin—NDUFS1—tendon—sarcoma	0.000353	0.00176	CbGeAlD
Metformin—NDUFB9—lymphoid tissue—sarcoma	0.000351	0.00175	CbGeAlD
Metformin—NDUFA8—lymphoid tissue—sarcoma	0.000351	0.00175	CbGeAlD
Metformin—NDUFB10—tendon—sarcoma	0.00035	0.00175	CbGeAlD
Metformin—ND3—testis—sarcoma	0.00035	0.00175	CbGeAlD
Metformin—ND2—testis—sarcoma	0.00035	0.00175	CbGeAlD
Metformin—ND4L—testis—sarcoma	0.00035	0.00175	CbGeAlD
Metformin—ND5—testis—sarcoma	0.00035	0.00175	CbGeAlD
Metformin—NDUFA4—lymphoid tissue—sarcoma	0.000349	0.00174	CbGeAlD
Metformin—NDUFS7—cardiac atrium—sarcoma	0.000348	0.00174	CbGeAlD
Metformin—NDUFB7—tendon—sarcoma	0.000348	0.00174	CbGeAlD
Metformin—NDUFA12—tendon—sarcoma	0.000348	0.00174	CbGeAlD
Metformin—NDUFA7—lymph node—sarcoma	0.000347	0.00173	CbGeAlD
Metformin—NDUFA5—bone marrow—sarcoma	0.000347	0.00173	CbGeAlD
Metformin—NDUFV1—lymphoid tissue—sarcoma	0.000347	0.00173	CbGeAlD
Metformin—NDUFB11—lymphoid tissue—sarcoma	0.000347	0.00173	CbGeAlD
Metformin—NDUFB1—tendon—sarcoma	0.000345	0.00173	CbGeAlD
Metformin—NDUFS8—tendon—sarcoma	0.000345	0.00173	CbGeAlD
Metformin—NDUFB8—lymphoid tissue—sarcoma	0.000345	0.00172	CbGeAlD
Metformin—NDUFS5—lymphoid tissue—sarcoma	0.000345	0.00172	CbGeAlD
Metformin—NDUFAF4—bone marrow—sarcoma	0.000344	0.00172	CbGeAlD
Metformin—NDUFB6—bone marrow—sarcoma	0.000344	0.00172	CbGeAlD
Metformin—NDUFS1—bone marrow—sarcoma	0.000342	0.00171	CbGeAlD
Metformin—NDUFB5—tendon—sarcoma	0.000341	0.0017	CbGeAlD
Metformin—NDUFA6—tendon—sarcoma	0.000341	0.0017	CbGeAlD
Metformin—NDUFB10—bone marrow—sarcoma	0.000339	0.00169	CbGeAlD
Metformin—ND4—testis—sarcoma	0.000339	0.00169	CbGeAlD
Metformin—NDUFS4—tendon—sarcoma	0.000338	0.00169	CbGeAlD
Metformin—NDUFA12—bone marrow—sarcoma	0.000337	0.00168	CbGeAlD
Metformin—NDUFB7—bone marrow—sarcoma	0.000337	0.00168	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—sarcoma	0.000335	0.00167	CbGeAlD
Metformin—NDUFS8—bone marrow—sarcoma	0.000334	0.00167	CbGeAlD
Metformin—NDUFB1—bone marrow—sarcoma	0.000334	0.00167	CbGeAlD
Metformin—NDUFB4—tendon—sarcoma	0.000334	0.00167	CbGeAlD
Metformin—NDUFAB1—tendon—sarcoma	0.000332	0.00166	CbGeAlD
Metformin—NDUFA2—testis—sarcoma	0.000332	0.00166	CbGeAlD
Metformin—ND2—liver—sarcoma	0.000331	0.00165	CbGeAlD
Metformin—ND5—liver—sarcoma	0.000331	0.00165	CbGeAlD
Metformin—ND3—liver—sarcoma	0.000331	0.00165	CbGeAlD
Metformin—ND4L—liver—sarcoma	0.000331	0.00165	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—sarcoma	0.000331	0.00165	CbGeAlD
Metformin—NDUFS2—skin of body—sarcoma	0.00033	0.00165	CbGeAlD
Metformin—NDUFA6—bone marrow—sarcoma	0.00033	0.00165	CbGeAlD
Metformin—NDUFB5—bone marrow—sarcoma	0.00033	0.00165	CbGeAlD
Metformin—NDUFA8—tendon—sarcoma	0.00033	0.00165	CbGeAlD
Metformin—NDUFB9—tendon—sarcoma	0.00033	0.00165	CbGeAlD
Metformin—NDUFA4—tendon—sarcoma	0.000328	0.00164	CbGeAlD
Metformin—NDUFS4—bone marrow—sarcoma	0.000328	0.00164	CbGeAlD
Metformin—NDUFS3—skin of body—sarcoma	0.000326	0.00163	CbGeAlD
Metformin—NDUFV1—tendon—sarcoma	0.000326	0.00163	CbGeAlD
Metformin—NDUFB11—tendon—sarcoma	0.000326	0.00163	CbGeAlD
Metformin—NDUFB8—tendon—sarcoma	0.000324	0.00162	CbGeAlD
Metformin—NDUFS5—tendon—sarcoma	0.000324	0.00162	CbGeAlD
Metformin—NDUFB4—bone marrow—sarcoma	0.000324	0.00162	CbGeAlD
Metformin—NDUFAB1—bone marrow—sarcoma	0.000322	0.00161	CbGeAlD
Metformin—ND4—liver—sarcoma	0.00032	0.0016	CbGeAlD
Metformin—NDUFB9—bone marrow—sarcoma	0.00032	0.0016	CbGeAlD
Metformin—NDUFA8—bone marrow—sarcoma	0.00032	0.0016	CbGeAlD
Metformin—NDUFA4—bone marrow—sarcoma	0.000318	0.00159	CbGeAlD
Metformin—PRKAB1—uterus—sarcoma	0.000317	0.00158	CbGeAlD
Metformin—NDUFA10—testis—sarcoma	0.000316	0.00158	CbGeAlD
Metformin—NDUFV1—bone marrow—sarcoma	0.000316	0.00158	CbGeAlD
Metformin—NDUFB11—bone marrow—sarcoma	0.000316	0.00158	CbGeAlD
Metformin—NDUFB8—bone marrow—sarcoma	0.000314	0.00157	CbGeAlD
Metformin—NDUFS5—bone marrow—sarcoma	0.000314	0.00157	CbGeAlD
Metformin—NDUFC1—testis—sarcoma	0.000314	0.00157	CbGeAlD
Metformin—NDUFA2—liver—sarcoma	0.000314	0.00157	CbGeAlD
Metformin—ND1—hematopoietic system—sarcoma	0.000312	0.00156	CbGeAlD
Metformin—NDUFB2—testis—sarcoma	0.000311	0.00155	CbGeAlD
Metformin—NDUFAF1—testis—sarcoma	0.000308	0.00154	CbGeAlD
Metformin—ND6—testis—sarcoma	0.000306	0.00153	CbGeAlD
Metformin—NDUFS7—tendon—sarcoma	0.000304	0.00152	CbGeAlD
Metformin—NDUFAF2—testis—sarcoma	0.000303	0.00152	CbGeAlD
Metformin—NDUFB3—testis—sarcoma	0.000303	0.00152	CbGeAlD
Metformin—NDUFC2—cardiac atrium—sarcoma	0.0003	0.0015	CbGeAlD
Metformin—NDUFA10—liver—sarcoma	0.000299	0.00149	CbGeAlD
Metformin—NDUFC2—uterus—sarcoma	0.000299	0.00149	CbGeAlD
Metformin—NDUFC1—liver—sarcoma	0.000297	0.00148	CbGeAlD
Metformin—NDUFA11—testis—sarcoma	0.000296	0.00148	CbGeAlD
Metformin—NDUFA5—testis—sarcoma	0.000296	0.00148	CbGeAlD
Metformin—NDUFAF4—testis—sarcoma	0.000294	0.00147	CbGeAlD
Metformin—NDUFB6—testis—sarcoma	0.000294	0.00147	CbGeAlD
Metformin—NDUFS7—bone marrow—sarcoma	0.000294	0.00147	CbGeAlD
Metformin—NDUFB2—liver—sarcoma	0.000294	0.00147	CbGeAlD
Metformin—NDUFS1—testis—sarcoma	0.000292	0.00146	CbGeAlD
Metformin—NDUFAF1—liver—sarcoma	0.000292	0.00146	CbGeAlD
Metformin—NDUFB10—testis—sarcoma	0.00029	0.00145	CbGeAlD
Metformin—ND6—liver—sarcoma	0.000289	0.00144	CbGeAlD
Metformin—NDUFS2—cardiac atrium—sarcoma	0.000289	0.00144	CbGeAlD
Metformin—NDUFA12—testis—sarcoma	0.000288	0.00144	CbGeAlD
Metformin—NDUFB7—testis—sarcoma	0.000288	0.00144	CbGeAlD
Metformin—NDUFS2—uterus—sarcoma	0.000287	0.00143	CbGeAlD
Metformin—NDUFB3—liver—sarcoma	0.000287	0.00143	CbGeAlD
Metformin—NDUFAF2—liver—sarcoma	0.000287	0.00143	CbGeAlD
Metformin—NDUFB1—testis—sarcoma	0.000286	0.00143	CbGeAlD
Metformin—NDUFS8—testis—sarcoma	0.000286	0.00143	CbGeAlD
Metformin—NDUFS3—cardiac atrium—sarcoma	0.000285	0.00142	CbGeAlD
Metformin—NDUFS3—uterus—sarcoma	0.000284	0.00142	CbGeAlD
Metformin—NDUFB5—testis—sarcoma	0.000282	0.00141	CbGeAlD
Metformin—NDUFA6—testis—sarcoma	0.000282	0.00141	CbGeAlD
Metformin—NDUFA5—liver—sarcoma	0.00028	0.0014	CbGeAlD
Metformin—NDUFA11—liver—sarcoma	0.00028	0.0014	CbGeAlD
Metformin—NDUFS4—testis—sarcoma	0.00028	0.0014	CbGeAlD
Metformin—NDUFC2—lymphoid tissue—sarcoma	0.000278	0.00139	CbGeAlD
Metformin—NDUFB6—liver—sarcoma	0.000278	0.00139	CbGeAlD
Metformin—NDUFAF4—liver—sarcoma	0.000278	0.00139	CbGeAlD
Metformin—PRKAB1—tendon—sarcoma	0.000278	0.00139	CbGeAlD
Metformin—NDUFV2—lymph node—sarcoma	0.000277	0.00139	CbGeAlD
Metformin—NDUFB4—testis—sarcoma	0.000277	0.00138	CbGeAlD
Metformin—NDUFS1—liver—sarcoma	0.000276	0.00138	CbGeAlD
Metformin—NDUFAB1—testis—sarcoma	0.000275	0.00137	CbGeAlD
Metformin—ND1—smooth muscle tissue—sarcoma	0.000275	0.00137	CbGeAlD
Metformin—NDUFB10—liver—sarcoma	0.000274	0.00137	CbGeAlD
Metformin—NDUFB9—testis—sarcoma	0.000273	0.00136	CbGeAlD
Metformin—NDUFA8—testis—sarcoma	0.000273	0.00136	CbGeAlD
Metformin—NDUFA12—liver—sarcoma	0.000272	0.00136	CbGeAlD
Metformin—NDUFB7—liver—sarcoma	0.000272	0.00136	CbGeAlD
Metformin—NDUFA4—testis—sarcoma	0.000271	0.00136	CbGeAlD
Metformin—ND1—skin of body—sarcoma	0.000271	0.00135	CbGeAlD
Metformin—NDUFB1—liver—sarcoma	0.00027	0.00135	CbGeAlD
Metformin—NDUFS8—liver—sarcoma	0.00027	0.00135	CbGeAlD
Metformin—NDUFB11—testis—sarcoma	0.00027	0.00135	CbGeAlD
Metformin—NDUFV1—testis—sarcoma	0.00027	0.00135	CbGeAlD
Metformin—NDUFA4L2—lymph node—sarcoma	0.00027	0.00135	CbGeAlD
Metformin—PRKAB1—bone marrow—sarcoma	0.000269	0.00134	CbGeAlD
Metformin—NDUFS5—testis—sarcoma	0.000268	0.00134	CbGeAlD
Metformin—NDUFB8—testis—sarcoma	0.000268	0.00134	CbGeAlD
Metformin—NDUFS2—lymphoid tissue—sarcoma	0.000268	0.00134	CbGeAlD
Metformin—NDUFA6—liver—sarcoma	0.000267	0.00133	CbGeAlD
Metformin—NDUFB5—liver—sarcoma	0.000267	0.00133	CbGeAlD
Metformin—NDUFS4—liver—sarcoma	0.000265	0.00132	CbGeAlD
Metformin—NDUFS3—lymphoid tissue—sarcoma	0.000264	0.00132	CbGeAlD
Metformin—NDUFC2—tendon—sarcoma	0.000262	0.00131	CbGeAlD
Metformin—NDUFB4—liver—sarcoma	0.000261	0.00131	CbGeAlD
Metformin—NDUFAB1—liver—sarcoma	0.00026	0.0013	CbGeAlD
Metformin—NDUFB9—liver—sarcoma	0.000258	0.00129	CbGeAlD
Metformin—NDUFA8—liver—sarcoma	0.000258	0.00129	CbGeAlD
Metformin—NDUFA4—liver—sarcoma	0.000257	0.00128	CbGeAlD
Metformin—NDUFV1—liver—sarcoma	0.000255	0.00127	CbGeAlD
Metformin—NDUFB11—liver—sarcoma	0.000255	0.00127	CbGeAlD
Metformin—ND3—lymph node—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—ND2—lymph node—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—ND5—lymph node—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—ND4L—lymph node—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—NDUFB8—liver—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—NDUFS5—liver—sarcoma	0.000254	0.00127	CbGeAlD
Metformin—NDUFC2—bone marrow—sarcoma	0.000253	0.00127	CbGeAlD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—MYC—sarcoma	0.000252	0.0184	CbGpPWpGaD
Metformin—NDUFS2—tendon—sarcoma	0.000252	0.00126	CbGeAlD
Metformin—NDUFS7—testis—sarcoma	0.000251	0.00126	CbGeAlD
Metformin—NDUFS3—tendon—sarcoma	0.000248	0.00124	CbGeAlD
Metformin—SLC47A1—myometrium—sarcoma	0.000247	0.00123	CbGeAlD
Metformin—ND4—lymph node—sarcoma	0.000245	0.00123	CbGeAlD
Metformin—NDUFS2—bone marrow—sarcoma	0.000244	0.00122	CbGeAlD
Metformin—NDUFS3—bone marrow—sarcoma	0.000241	0.0012	CbGeAlD
Metformin—NDUFA2—lymph node—sarcoma	0.00024	0.0012	CbGeAlD
Metformin—NDUFS7—liver—sarcoma	0.000238	0.00119	CbGeAlD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	0.000233	0.017	CbGpPWpGaD
Metformin—PRKAB1—testis—sarcoma	0.00023	0.00115	CbGeAlD
Metformin—NDUFA10—lymph node—sarcoma	0.000229	0.00115	CbGeAlD
Metformin—NDUFC1—lymph node—sarcoma	0.000227	0.00114	CbGeAlD
Metformin—NDUFB2—lymph node—sarcoma	0.000225	0.00113	CbGeAlD
Metformin—Feeling abnormal—Thiotepa—sarcoma	0.000225	0.00258	CcSEcCtD
Metformin—Anorexia—Mitoxantrone—sarcoma	0.000225	0.00257	CcSEcCtD
Metformin—Pain in extremity—Epirubicin—sarcoma	0.000224	0.00256	CcSEcCtD
Metformin—NDUFAF1—lymph node—sarcoma	0.000224	0.00112	CbGeAlD
Metformin—Feeling abnormal—Dactinomycin—sarcoma	0.000223	0.00256	CcSEcCtD
Metformin—Gastrointestinal pain—Thiotepa—sarcoma	0.000223	0.00256	CcSEcCtD
Metformin—Ill-defined disorder—Etoposide—sarcoma	0.000223	0.00255	CcSEcCtD
Metformin—SLC47A1—seminal vesicle—sarcoma	0.000223	0.00111	CbGeAlD
Metformin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000222	0.00254	CcSEcCtD
Metformin—ND6—lymph node—sarcoma	0.000222	0.00111	CbGeAlD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—ATF1—sarcoma	0.000221	0.0161	CbGpPWpGaD
Metformin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000221	0.00252	CcSEcCtD
Metformin—Hypotension—Mitoxantrone—sarcoma	0.00022	0.00252	CcSEcCtD
Metformin—Migraine—Epirubicin—sarcoma	0.00022	0.00252	CcSEcCtD
Metformin—NDUFB3—lymph node—sarcoma	0.00022	0.0011	CbGeAlD
Metformin—NDUFAF2—lymph node—sarcoma	0.00022	0.0011	CbGeAlD
Metformin—ND1—lymphoid tissue—sarcoma	0.00022	0.0011	CbGeAlD
Metformin—Renal impairment—Doxorubicin—sarcoma	0.000218	0.00249	CcSEcCtD
Metformin—NDUFV3—FOXA1 transcription factor network—JUN—sarcoma	0.000218	0.0159	CbGpPWpGaD
Metformin—Paraesthesia—Vincristine—sarcoma	0.000218	0.00249	CcSEcCtD
Metformin—PRKAB1—liver—sarcoma	0.000217	0.00109	CbGeAlD
Metformin—Urticaria—Thiotepa—sarcoma	0.000217	0.00248	CcSEcCtD
Metformin—Malaise—Etoposide—sarcoma	0.000217	0.00248	CcSEcCtD
Metformin—NDUFC2—testis—sarcoma	0.000217	0.00108	CbGeAlD
Metformin—Abdominal pain—Thiotepa—sarcoma	0.000216	0.00247	CcSEcCtD
Metformin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000215	0.00246	CcSEcCtD
Metformin—NDUFA5—lymph node—sarcoma	0.000215	0.00107	CbGeAlD
Metformin—NDUFA11—lymph node—sarcoma	0.000215	0.00107	CbGeAlD
Metformin—Abdominal pain—Dactinomycin—sarcoma	0.000214	0.00245	CcSEcCtD
Metformin—NDUFB6—lymph node—sarcoma	0.000213	0.00107	CbGeAlD
Metformin—NDUFAF4—lymph node—sarcoma	0.000213	0.00107	CbGeAlD
Metformin—Hypoglycaemia—Doxorubicin—sarcoma	0.000212	0.00243	CcSEcCtD
Metformin—Paraesthesia—Mitoxantrone—sarcoma	0.000212	0.00242	CcSEcCtD
Metformin—SLC47A1—hematopoietic system—sarcoma	0.000212	0.00106	CbGeAlD
Metformin—NDUFS1—lymph node—sarcoma	0.000212	0.00106	CbGeAlD
Metformin—Loss of consciousness—Etoposide—sarcoma	0.000211	0.00242	CcSEcCtD
Metformin—Lethargy—Doxorubicin—sarcoma	0.000211	0.00242	CcSEcCtD
Metformin—Decreased appetite—Vincristine—sarcoma	0.000211	0.00241	CcSEcCtD
Metformin—Dyspnoea—Mitoxantrone—sarcoma	0.00021	0.00241	CcSEcCtD
Metformin—NDUFB10—lymph node—sarcoma	0.00021	0.00105	CbGeAlD
Metformin—Somnolence—Mitoxantrone—sarcoma	0.00021	0.0024	CcSEcCtD
Metformin—Gastrointestinal disorder—Vincristine—sarcoma	0.000209	0.00239	CcSEcCtD
Metformin—Fatigue—Vincristine—sarcoma	0.000209	0.00239	CcSEcCtD
Metformin—NDUFB7—lymph node—sarcoma	0.000209	0.00104	CbGeAlD
Metformin—NDUFA12—lymph node—sarcoma	0.000209	0.00104	CbGeAlD
Metformin—NDUFS2—testis—sarcoma	0.000208	0.00104	CbGeAlD
Metformin—Dehydration—Epirubicin—sarcoma	0.000208	0.00238	CcSEcCtD
Metformin—Dyspepsia—Mitoxantrone—sarcoma	0.000208	0.00238	CcSEcCtD
Metformin—Hypertension—Etoposide—sarcoma	0.000208	0.00237	CcSEcCtD
Metformin—NDUFS8—lymph node—sarcoma	0.000207	0.00104	CbGeAlD
Metformin—NDUFB1—lymph node—sarcoma	0.000207	0.00104	CbGeAlD
Metformin—Constipation—Vincristine—sarcoma	0.000207	0.00237	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—sarcoma	0.000207	0.00237	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—sarcoma	0.000207	0.00236	CcSEcCtD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—TP53—sarcoma	0.000207	0.0151	CbGpPWpGaD
Metformin—NDUFS3—testis—sarcoma	0.000206	0.00103	CbGeAlD
Metformin—Decreased appetite—Mitoxantrone—sarcoma	0.000205	0.00235	CcSEcCtD
Metformin—NDUFC2—liver—sarcoma	0.000205	0.00102	CbGeAlD
Metformin—Chest pain—Etoposide—sarcoma	0.000205	0.00234	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—sarcoma	0.000204	0.00234	CcSEcCtD
Metformin—NDUFB5—lymph node—sarcoma	0.000204	0.00102	CbGeAlD
Metformin—NDUFA6—lymph node—sarcoma	0.000204	0.00102	CbGeAlD
Metformin—Migraine—Doxorubicin—sarcoma	0.000204	0.00233	CcSEcCtD
Metformin—Fatigue—Mitoxantrone—sarcoma	0.000203	0.00233	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000203	0.00233	CcSEcCtD
Metformin—NDUFS4—lymph node—sarcoma	0.000203	0.00101	CbGeAlD
Metformin—Discomfort—Etoposide—sarcoma	0.000202	0.00231	CcSEcCtD
Metformin—Breast disorder—Epirubicin—sarcoma	0.000202	0.00231	CcSEcCtD
Metformin—Constipation—Mitoxantrone—sarcoma	0.000202	0.00231	CcSEcCtD
Metformin—NDUFB4—lymph node—sarcoma	0.0002	0.001	CbGeAlD
Metformin—Nasopharyngitis—Epirubicin—sarcoma	0.0002	0.00229	CcSEcCtD
Metformin—ND1—bone marrow—sarcoma	0.0002	0.000999	CbGeAlD
Metformin—NDUFAB1—lymph node—sarcoma	0.000199	0.000995	CbGeAlD
Metformin—Gastrointestinal pain—Vincristine—sarcoma	0.000198	0.00227	CcSEcCtD
Metformin—NDUFA8—lymph node—sarcoma	0.000198	0.000989	CbGeAlD
Metformin—NDUFB9—lymph node—sarcoma	0.000198	0.000989	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—COL18A1—sarcoma	0.000198	0.0145	CbGpPWpGaD
Metformin—NDUFS2—liver—sarcoma	0.000197	0.000984	CbGeAlD
Metformin—NDUFA4—lymph node—sarcoma	0.000197	0.000983	CbGeAlD
Metformin—SLC22A3—myometrium—sarcoma	0.000197	0.000983	CbGeAlD
Metformin—Asthenia—Thiotepa—sarcoma	0.000196	0.00224	CcSEcCtD
Metformin—NDUFV1—lymph node—sarcoma	0.000196	0.000977	CbGeAlD
Metformin—NDUFB11—lymph node—sarcoma	0.000196	0.000977	CbGeAlD
Metformin—Infection—Etoposide—sarcoma	0.000195	0.00223	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—sarcoma	0.000195	0.00223	CcSEcCtD
Metformin—Asthenia—Dactinomycin—sarcoma	0.000195	0.00223	CcSEcCtD
Metformin—NDUFS3—liver—sarcoma	0.000195	0.000972	CbGeAlD
Metformin—NDUFS5—lymph node—sarcoma	0.000194	0.000972	CbGeAlD
Metformin—NDUFB8—lymph node—sarcoma	0.000194	0.000972	CbGeAlD
Metformin—Feeling abnormal—Mitoxantrone—sarcoma	0.000194	0.00222	CcSEcCtD
Metformin—Influenza—Epirubicin—sarcoma	0.000193	0.00221	CcSEcCtD
Metformin—Pruritus—Thiotepa—sarcoma	0.000193	0.00221	CcSEcCtD
Metformin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000193	0.00221	CcSEcCtD
Metformin—Dehydration—Doxorubicin—sarcoma	0.000193	0.0022	CcSEcCtD
Metformin—Thrombocytopenia—Etoposide—sarcoma	0.000192	0.0022	CcSEcCtD
Metformin—Abdominal pain—Vincristine—sarcoma	0.000192	0.00219	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—sarcoma	0.000191	0.00219	CcSEcCtD
Metformin—Skin disorder—Etoposide—sarcoma	0.000191	0.00218	CcSEcCtD
Metformin—Hyperhidrosis—Etoposide—sarcoma	0.00019	0.00217	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—sarcoma	0.00019	0.00217	CcSEcCtD
Metformin—SLC22A3—embryo—sarcoma	0.000189	0.000945	CbGeAlD
Metformin—Abdominal pain upper—Doxorubicin—sarcoma	0.000189	0.00216	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—sarcoma	0.000188	0.00216	CcSEcCtD
Metformin—Urticaria—Mitoxantrone—sarcoma	0.000187	0.00214	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—sarcoma	0.000187	0.00214	CcSEcCtD
Metformin—Anorexia—Etoposide—sarcoma	0.000187	0.00214	CcSEcCtD
Metformin—Diarrhoea—Thiotepa—sarcoma	0.000187	0.00214	CcSEcCtD
Metformin—Abdominal pain—Mitoxantrone—sarcoma	0.000187	0.00213	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—sarcoma	0.000186	0.00212	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—sarcoma	0.000185	0.00212	CcSEcCtD
Metformin—Hypotension—Etoposide—sarcoma	0.000183	0.0021	CcSEcCtD
Metformin—NDUFS7—lymph node—sarcoma	0.000182	0.00091	CbGeAlD
Metformin—Neutropenia—Epirubicin—sarcoma	0.000181	0.00207	CcSEcCtD
Metformin—Dizziness—Thiotepa—sarcoma	0.000181	0.00207	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—sarcoma	0.00018	0.00206	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—sarcoma	0.00018	0.00206	CcSEcCtD
Metformin—PRKAB1—Membrane Trafficking—GJA4—sarcoma	0.000179	0.0131	CbGpPWpGaD
Metformin—Influenza—Doxorubicin—sarcoma	0.000179	0.00205	CcSEcCtD
Metformin—SLC22A3—seminal vesicle—sarcoma	0.000178	0.000888	CbGeAlD
Metformin—Paraesthesia—Etoposide—sarcoma	0.000176	0.00202	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—sarcoma	0.000176	0.00201	CcSEcCtD
Metformin—Dyspnoea—Etoposide—sarcoma	0.000175	0.002	CcSEcCtD
Metformin—Somnolence—Etoposide—sarcoma	0.000174	0.002	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—sarcoma	0.000174	0.00199	CcSEcCtD
Metformin—Asthenia—Vincristine—sarcoma	0.000174	0.00199	CcSEcCtD
Metformin—Vomiting—Thiotepa—sarcoma	0.000174	0.00199	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Infestation—Epirubicin—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Drowsiness—Epirubicin—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Vomiting—Dactinomycin—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Rash—Thiotepa—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Dermatitis—Thiotepa—sarcoma	0.000172	0.00197	CcSEcCtD
Metformin—Headache—Thiotepa—sarcoma	0.000171	0.00196	CcSEcCtD
Metformin—Rash—Dactinomycin—sarcoma	0.000171	0.00196	CcSEcCtD
Metformin—ND1—testis—sarcoma	0.000171	0.000854	CbGeAlD
Metformin—Decreased appetite—Etoposide—sarcoma	0.000171	0.00195	CcSEcCtD
Metformin—Gastrointestinal disorder—Etoposide—sarcoma	0.000169	0.00194	CcSEcCtD
Metformin—Asthenia—Mitoxantrone—sarcoma	0.000169	0.00194	CcSEcCtD
Metformin—Fatigue—Etoposide—sarcoma	0.000169	0.00194	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—sarcoma	0.000169	0.00193	CcSEcCtD
Metformin—SLC22A3—hematopoietic system—sarcoma	0.000169	0.000844	CbGeAlD
Metformin—Constipation—Etoposide—sarcoma	0.000168	0.00192	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—sarcoma	0.000167	0.00191	CcSEcCtD
Metformin—PRKAB1—lymph node—sarcoma	0.000167	0.000833	CbGeAlD
Metformin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000166	0.0019	CcSEcCtD
Metformin—Diarrhoea—Vincristine—sarcoma	0.000166	0.0019	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	0.000165	0.0121	CbGpPWpGaD
Metformin—Hepatobiliary disease—Epirubicin—sarcoma	0.000163	0.00187	CcSEcCtD
Metformin—SLC22A3—connective tissue—sarcoma	0.000163	0.000813	CbGeAlD
Metformin—Nausea—Thiotepa—sarcoma	0.000162	0.00186	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—sarcoma	0.000162	0.00185	CcSEcCtD
Metformin—NDUFV3—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000162	0.0118	CbGpPWpGaD
Metformin—ND1—liver—sarcoma	0.000162	0.000807	CbGeAlD
Metformin—Diarrhoea—Mitoxantrone—sarcoma	0.000161	0.00185	CcSEcCtD
Metformin—NDUFV3—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000161	0.0118	CbGpPWpGaD
Metformin—Nausea—Dactinomycin—sarcoma	0.000161	0.00184	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—sarcoma	0.00016	0.00184	CcSEcCtD
Metformin—Dizziness—Vincristine—sarcoma	0.00016	0.00183	CcSEcCtD
Metformin—SLC47A1—uterus—sarcoma	0.00016	0.000799	CbGeAlD
Metformin—Infestation—Doxorubicin—sarcoma	0.00016	0.00183	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—sarcoma	0.00016	0.00183	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—sarcoma	0.00016	0.00183	CcSEcCtD
Metformin—Bradycardia—Epirubicin—sarcoma	0.000158	0.0018	CcSEcCtD
Metformin—NDUFC2—lymph node—sarcoma	0.000157	0.000785	CbGeAlD
Metformin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000156	0.00179	CcSEcCtD
Metformin—Urticaria—Etoposide—sarcoma	0.000156	0.00178	CcSEcCtD
Metformin—Rhinitis—Epirubicin—sarcoma	0.000155	0.00178	CcSEcCtD
Metformin—Abdominal pain—Etoposide—sarcoma	0.000155	0.00177	CcSEcCtD
Metformin—Hepatitis—Epirubicin—sarcoma	0.000155	0.00177	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—sarcoma	0.000154	0.00176	CcSEcCtD
Metformin—Vomiting—Vincristine—sarcoma	0.000154	0.00176	CcSEcCtD
Metformin—Rash—Vincristine—sarcoma	0.000153	0.00175	CcSEcCtD
Metformin—Dermatitis—Vincristine—sarcoma	0.000153	0.00175	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—sarcoma	0.000153	0.00174	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—sarcoma	0.000152	0.00174	CcSEcCtD
Metformin—Headache—Vincristine—sarcoma	0.000152	0.00174	CcSEcCtD
Metformin—NDUFS2—lymph node—sarcoma	0.000151	0.000754	CbGeAlD
Metformin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000151	0.00173	CcSEcCtD
Metformin—Vomiting—Mitoxantrone—sarcoma	0.00015	0.00172	CcSEcCtD
Metformin—NDUFS3—lymph node—sarcoma	0.000149	0.000745	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—sarcoma	0.000149	0.000743	CbGeAlD
Metformin—Rash—Mitoxantrone—sarcoma	0.000149	0.0017	CcSEcCtD
Metformin—Dermatitis—Mitoxantrone—sarcoma	0.000149	0.0017	CcSEcCtD
Metformin—Headache—Mitoxantrone—sarcoma	0.000148	0.00169	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—sarcoma	0.000146	0.00167	CcSEcCtD
Metformin—Eye disorder—Epirubicin—sarcoma	0.000145	0.00166	CcSEcCtD
Metformin—Nausea—Vincristine—sarcoma	0.000144	0.00165	CcSEcCtD
Metformin—Flushing—Epirubicin—sarcoma	0.000144	0.00164	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—sarcoma	0.000144	0.00164	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—sarcoma	0.000144	0.00164	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—sarcoma	0.000143	0.00164	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—sarcoma	0.000143	0.00163	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—sarcoma	0.000141	0.00161	CcSEcCtD
Metformin—Asthenia—Etoposide—sarcoma	0.000141	0.00161	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—sarcoma	0.000141	0.00161	CcSEcCtD
Metformin—Angiopathy—Epirubicin—sarcoma	0.00014	0.00161	CcSEcCtD
Metformin—SLC47A1—tendon—sarcoma	0.00014	0.0007	CbGeAlD
Metformin—Nausea—Mitoxantrone—sarcoma	0.00014	0.0016	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—sarcoma	0.00014	0.0016	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—sarcoma	0.00014	0.0016	CcSEcCtD
Metformin—Chills—Epirubicin—sarcoma	0.000139	0.00159	CcSEcCtD
Metformin—Pruritus—Etoposide—sarcoma	0.000139	0.00159	CcSEcCtD
Metformin—Malnutrition—Epirubicin—sarcoma	0.000135	0.00154	CcSEcCtD
Metformin—Erythema—Epirubicin—sarcoma	0.000135	0.00154	CcSEcCtD
Metformin—Diarrhoea—Etoposide—sarcoma	0.000134	0.00154	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—sarcoma	0.000134	0.00153	CcSEcCtD
Metformin—Flushing—Doxorubicin—sarcoma	0.000133	0.00152	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—sarcoma	0.000133	0.00152	CcSEcCtD
Metformin—Flatulence—Epirubicin—sarcoma	0.000133	0.00152	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—sarcoma	0.000132	0.00151	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—sarcoma	0.00013	0.00149	CcSEcCtD
Metformin—PRKAB1—Mitochondrial biogenesis—CREB1—sarcoma	0.00013	0.0095	CbGpPWpGaD
Metformin—Dizziness—Etoposide—sarcoma	0.00013	0.00148	CcSEcCtD
Metformin—NDUFV3—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.00013	0.00948	CbGpPWpGaD
Metformin—Muscle spasms—Epirubicin—sarcoma	0.00013	0.00148	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—sarcoma	0.000129	0.00148	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—sarcoma	0.000129	0.00148	CcSEcCtD
Metformin—Chills—Doxorubicin—sarcoma	0.000129	0.00147	CcSEcCtD
Metformin—Vision blurred—Epirubicin—sarcoma	0.000127	0.00145	CcSEcCtD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—IGF1R—sarcoma	0.000126	0.00922	CbGpPWpGaD
Metformin—NDUFS2—p73 transcription factor network—MDM2—sarcoma	0.000125	0.00916	CbGpPWpGaD
Metformin—Ill-defined disorder—Epirubicin—sarcoma	0.000125	0.00143	CcSEcCtD
Metformin—Vomiting—Etoposide—sarcoma	0.000125	0.00143	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—sarcoma	0.000125	0.00143	CcSEcCtD
Metformin—Erythema—Doxorubicin—sarcoma	0.000125	0.00143	CcSEcCtD
Metformin—ND1—lymph node—sarcoma	0.000124	0.000619	CbGeAlD
Metformin—Rash—Etoposide—sarcoma	0.000124	0.00142	CcSEcCtD
Metformin—Dermatitis—Etoposide—sarcoma	0.000124	0.00141	CcSEcCtD
Metformin—Headache—Etoposide—sarcoma	0.000123	0.00141	CcSEcCtD
Metformin—Flatulence—Doxorubicin—sarcoma	0.000123	0.00141	CcSEcCtD
Metformin—PRKAB1—IGF1R signaling cascade—IGF1R—sarcoma	0.000123	0.00898	CbGpPWpGaD
Metformin—Dysgeusia—Doxorubicin—sarcoma	0.000122	0.0014	CcSEcCtD
Metformin—Malaise—Epirubicin—sarcoma	0.000122	0.00139	CcSEcCtD
Metformin—Syncope—Epirubicin—sarcoma	0.000121	0.00138	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—sarcoma	0.00012	0.00137	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—CREB1—sarcoma	0.00012	0.00875	CbGpPWpGaD
Metformin—Palpitations—Epirubicin—sarcoma	0.000119	0.00136	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—sarcoma	0.000118	0.00136	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—sarcoma	0.000118	0.00134	CcSEcCtD
Metformin—Nausea—Etoposide—sarcoma	0.000117	0.00133	CcSEcCtD
Metformin—Hypertension—Epirubicin—sarcoma	0.000116	0.00133	CcSEcCtD
Metformin—SLC47A1—testis—sarcoma	0.000116	0.00058	CbGeAlD
Metformin—Ill-defined disorder—Doxorubicin—sarcoma	0.000116	0.00132	CcSEcCtD
Metformin—Chest pain—Epirubicin—sarcoma	0.000115	0.00131	CcSEcCtD
Metformin—Myalgia—Epirubicin—sarcoma	0.000115	0.00131	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000114	0.0013	CcSEcCtD
Metformin—Discomfort—Epirubicin—sarcoma	0.000113	0.0013	CcSEcCtD
Metformin—Malaise—Doxorubicin—sarcoma	0.000112	0.00129	CcSEcCtD
Metformin—Syncope—Doxorubicin—sarcoma	0.000112	0.00128	CcSEcCtD
Metformin—Palpitations—Doxorubicin—sarcoma	0.00011	0.00126	CcSEcCtD
Metformin—Oedema—Epirubicin—sarcoma	0.00011	0.00126	CcSEcCtD
Metformin—SLC47A1—liver—sarcoma	0.00011	0.000548	CbGeAlD
Metformin—Loss of consciousness—Doxorubicin—sarcoma	0.00011	0.00125	CcSEcCtD
Metformin—Infection—Epirubicin—sarcoma	0.000109	0.00125	CcSEcCtD
Metformin—Shock—Epirubicin—sarcoma	0.000108	0.00124	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—sarcoma	0.000108	0.00123	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—sarcoma	0.000108	0.00123	CcSEcCtD
Metformin—Hypertension—Doxorubicin—sarcoma	0.000108	0.00123	CcSEcCtD
Metformin—Skin disorder—Epirubicin—sarcoma	0.000107	0.00122	CcSEcCtD
Metformin—PRKAB1—SREBP signalling—CREB1—sarcoma	0.000107	0.0078	CbGpPWpGaD
Metformin—Hyperhidrosis—Epirubicin—sarcoma	0.000106	0.00122	CcSEcCtD
Metformin—Chest pain—Doxorubicin—sarcoma	0.000106	0.00121	CcSEcCtD
Metformin—Myalgia—Doxorubicin—sarcoma	0.000106	0.00121	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000105	0.00121	CcSEcCtD
Metformin—Discomfort—Doxorubicin—sarcoma	0.000105	0.0012	CcSEcCtD
Metformin—Anorexia—Epirubicin—sarcoma	0.000105	0.0012	CcSEcCtD
Metformin—Hypotension—Epirubicin—sarcoma	0.000103	0.00118	CcSEcCtD
Metformin—Oedema—Doxorubicin—sarcoma	0.000102	0.00116	CcSEcCtD
Metformin—Infection—Doxorubicin—sarcoma	0.000101	0.00116	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.0001	0.00115	CcSEcCtD
Metformin—Shock—Doxorubicin—sarcoma	0.0001	0.00115	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—sarcoma	9.98e-05	0.00114	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—sarcoma	9.97e-05	0.00114	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—sarcoma	9.89e-05	0.00113	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—sarcoma	9.88e-05	0.00113	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—sarcoma	9.84e-05	0.00113	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—sarcoma	9.81e-05	0.00112	CcSEcCtD
Metformin—Somnolence—Epirubicin—sarcoma	9.78e-05	0.00112	CcSEcCtD
Metformin—Anorexia—Doxorubicin—sarcoma	9.7e-05	0.00111	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—sarcoma	9.68e-05	0.00111	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—sarcoma	9.56e-05	0.00109	CcSEcCtD
Metformin—Hypotension—Doxorubicin—sarcoma	9.51e-05	0.00109	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—sarcoma	9.5e-05	0.00109	CcSEcCtD
Metformin—Fatigue—Epirubicin—sarcoma	9.49e-05	0.00108	CcSEcCtD
Metformin—Constipation—Epirubicin—sarcoma	9.41e-05	0.00108	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.27e-05	0.00106	CcSEcCtD
Metformin—SLC22A3—testis—sarcoma	9.26e-05	0.000463	CbGeAlD
Metformin—SLC22A1—liver—sarcoma	9.16e-05	0.000458	CbGeAlD
Metformin—Paraesthesia—Doxorubicin—sarcoma	9.14e-05	0.00105	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—sarcoma	9.08e-05	0.00104	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—sarcoma	9.07e-05	0.00104	CcSEcCtD
Metformin—Somnolence—Doxorubicin—sarcoma	9.05e-05	0.00104	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—sarcoma	9e-05	0.00103	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—sarcoma	8.96e-05	0.00102	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—sarcoma	8.85e-05	0.00101	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—sarcoma	8.79e-05	0.00101	CcSEcCtD
Metformin—Fatigue—Doxorubicin—sarcoma	8.78e-05	0.001	CcSEcCtD
Metformin—NDUFS2—p73 transcription factor network—MYC—sarcoma	8.76e-05	0.0064	CbGpPWpGaD
Metformin—SLC22A3—liver—sarcoma	8.75e-05	0.000437	CbGeAlD
Metformin—Urticaria—Epirubicin—sarcoma	8.74e-05	0.001	CcSEcCtD
Metformin—Constipation—Doxorubicin—sarcoma	8.71e-05	0.000996	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—sarcoma	8.7e-05	0.000995	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—JUN—sarcoma	8.61e-05	0.00629	CbGpPWpGaD
Metformin—SLC47A1—lymph node—sarcoma	8.41e-05	0.00042	CbGeAlD
Metformin—Feeling abnormal—Doxorubicin—sarcoma	8.39e-05	0.000959	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—sarcoma	8.32e-05	0.000952	CcSEcCtD
Metformin—Urticaria—Doxorubicin—sarcoma	8.09e-05	0.000925	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—sarcoma	8.05e-05	0.00092	CcSEcCtD
Metformin—Asthenia—Epirubicin—sarcoma	7.89e-05	0.000903	CcSEcCtD
Metformin—Pruritus—Epirubicin—sarcoma	7.78e-05	0.00089	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—SRC—sarcoma	7.72e-05	0.00564	CbGpPWpGaD
Metformin—Diarrhoea—Epirubicin—sarcoma	7.53e-05	0.000861	CcSEcCtD
Metformin—Asthenia—Doxorubicin—sarcoma	7.3e-05	0.000835	CcSEcCtD
Metformin—Dizziness—Epirubicin—sarcoma	7.28e-05	0.000832	CcSEcCtD
Metformin—Pruritus—Doxorubicin—sarcoma	7.2e-05	0.000824	CcSEcCtD
Metformin—Vomiting—Epirubicin—sarcoma	7e-05	0.0008	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—sarcoma	6.96e-05	0.000797	CcSEcCtD
Metformin—Rash—Epirubicin—sarcoma	6.94e-05	0.000793	CcSEcCtD
Metformin—Dermatitis—Epirubicin—sarcoma	6.93e-05	0.000793	CcSEcCtD
Metformin—Headache—Epirubicin—sarcoma	6.89e-05	0.000788	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—EGFR—sarcoma	6.77e-05	0.00495	CbGpPWpGaD
Metformin—Dizziness—Doxorubicin—sarcoma	6.73e-05	0.00077	CcSEcCtD
Metformin—SLC22A3—lymph node—sarcoma	6.71e-05	0.000335	CbGeAlD
Metformin—Nausea—Epirubicin—sarcoma	6.53e-05	0.000747	CcSEcCtD
Metformin—Vomiting—Doxorubicin—sarcoma	6.47e-05	0.00074	CcSEcCtD
Metformin—Rash—Doxorubicin—sarcoma	6.42e-05	0.000734	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—sarcoma	6.41e-05	0.000733	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—KRAS—sarcoma	6.39e-05	0.00467	CbGpPWpGaD
Metformin—Headache—Doxorubicin—sarcoma	6.38e-05	0.000729	CcSEcCtD
Metformin—Nausea—Doxorubicin—sarcoma	6.05e-05	0.000692	CcSEcCtD
Metformin—PRKAB1—Organelle biogenesis and maintenance—CREB1—sarcoma	5.89e-05	0.00431	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—MMP2—sarcoma	5.64e-05	0.00413	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—NRAS—sarcoma	5.61e-05	0.0041	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—NRAS—sarcoma	5.45e-05	0.00399	CbGpPWpGaD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—HRAS—sarcoma	5.43e-05	0.00397	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—NRAS—sarcoma	5.4e-05	0.00395	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—NRAS—sarcoma	5.26e-05	0.00385	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—NRAS—sarcoma	5.26e-05	0.00385	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—ENO2—sarcoma	5.25e-05	0.00384	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—HBA1—sarcoma	5.22e-05	0.00382	CbGpPWpGaD
Metformin—PRKAB1—AMPK Signaling—TP53—sarcoma	5.07e-05	0.00371	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—MDM2—sarcoma	5.01e-05	0.00367	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—KRAS—sarcoma	4.83e-05	0.00353	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—ENO2—sarcoma	4.81e-05	0.00351	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—ENO2—sarcoma	4.81e-05	0.00351	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—ENO2—sarcoma	4.81e-05	0.00351	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—ENO2—sarcoma	4.81e-05	0.00351	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—HBA1—sarcoma	4.78e-05	0.00349	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—HBA1—sarcoma	4.78e-05	0.00349	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—HBA1—sarcoma	4.78e-05	0.00349	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—HBA1—sarcoma	4.78e-05	0.00349	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—KRAS—sarcoma	4.69e-05	0.00343	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—KRAS—sarcoma	4.65e-05	0.0034	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—KRAS—sarcoma	4.53e-05	0.00331	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—KRAS—sarcoma	4.53e-05	0.00331	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND6—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND4L—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND2—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND3—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND5—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—ND4—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—ENO2—sarcoma	4.47e-05	0.00327	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PLCG1—sarcoma	4.46e-05	0.00326	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND3—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND4L—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND2—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND5—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND6—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—ND4—Metabolism—HBA1—sarcoma	4.44e-05	0.00325	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—NRAS—sarcoma	4.37e-05	0.0032	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—JUN—sarcoma	4.36e-05	0.00319	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—HRAS—sarcoma	4.1e-05	0.003	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PLCG1—sarcoma	4.08e-05	0.00298	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PLCG1—sarcoma	4.08e-05	0.00298	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PLCG1—sarcoma	4.08e-05	0.00298	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PLCG1—sarcoma	4.08e-05	0.00298	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—HRAS—sarcoma	3.99e-05	0.00292	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—ENO2—sarcoma	3.98e-05	0.00291	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—HBA1—sarcoma	3.96e-05	0.00289	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—HRAS—sarcoma	3.95e-05	0.00289	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—HRAS—sarcoma	3.85e-05	0.00281	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—HRAS—sarcoma	3.85e-05	0.00281	CbGpPWpGaD
Metformin—ND4—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—ND6—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—ND2—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—ND4L—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—ND3—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—ND5—Metabolism—PLCG1—sarcoma	3.79e-05	0.00277	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—KRAS—sarcoma	3.76e-05	0.00275	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—EGFR—sarcoma	3.43e-05	0.00251	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ENO2—sarcoma	3.39e-05	0.00248	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ENO2—sarcoma	3.39e-05	0.00248	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ENO2—sarcoma	3.39e-05	0.00248	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PLCG1—sarcoma	3.38e-05	0.00247	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—HBA1—sarcoma	3.36e-05	0.00246	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—HBA1—sarcoma	3.36e-05	0.00246	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—HBA1—sarcoma	3.36e-05	0.00246	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—HRAS—sarcoma	3.2e-05	0.00234	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ENO2—sarcoma	3.18e-05	0.00233	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—HBA1—sarcoma	3.16e-05	0.00231	CbGpPWpGaD
Metformin—PRKAB1—Membrane Trafficking—SRC—sarcoma	3.06e-05	0.00224	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—TP53—sarcoma	2.88e-05	0.0021	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PLCG1—sarcoma	2.87e-05	0.0021	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PLCG1—sarcoma	2.87e-05	0.0021	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PLCG1—sarcoma	2.87e-05	0.0021	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PLCG1—sarcoma	2.7e-05	0.00197	CbGpPWpGaD
Metformin—ND1—Metabolism—ENO2—sarcoma	2.18e-05	0.00159	CbGpPWpGaD
Metformin—ND1—Metabolism—HBA1—sarcoma	2.17e-05	0.00158	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TLE1—sarcoma	2.15e-05	0.00158	CbGpPWpGaD
Metformin—ND1—Metabolism—PLCG1—sarcoma	1.85e-05	0.00135	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFC—sarcoma	1.82e-05	0.00133	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FLT1—sarcoma	1.45e-05	0.00106	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	1.44e-05	0.00105	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PLCG1—sarcoma	1.43e-05	0.00104	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCR4—sarcoma	1.37e-05	0.001	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ATF1—sarcoma	1.36e-05	0.000992	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	1.34e-05	0.000983	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	1.19e-05	0.000873	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	1.11e-05	0.000813	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—CREB1—sarcoma	1.11e-05	0.000808	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1R—sarcoma	1.06e-05	0.000778	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—CREB1—sarcoma	1.03e-05	0.000753	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO2—sarcoma	1.02e-05	0.000743	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FOXO1—sarcoma	1.01e-05	0.000741	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFRB—sarcoma	1.01e-05	0.00074	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HBA1—sarcoma	1.01e-05	0.000738	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFRA—sarcoma	9.96e-06	0.000728	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—sarcoma	9.15e-06	0.000669	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PLCG1—sarcoma	8.62e-06	0.00063	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—sarcoma	8.52e-06	0.000623	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—sarcoma	8.38e-06	0.000613	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—sarcoma	7.72e-06	0.000565	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREB1—sarcoma	7.35e-06	0.000537	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	6.55e-06	0.000479	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—sarcoma	6.37e-06	0.000466	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HBA1—sarcoma	6.33e-06	0.000463	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	6.11e-06	0.000446	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—sarcoma	6.08e-06	0.000445	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—sarcoma	5.94e-06	0.000434	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HBA1—sarcoma	5.9e-06	0.000432	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—sarcoma	5.43e-06	0.000397	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLCG1—sarcoma	5.41e-06	0.000395	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—sarcoma	5.3e-06	0.000387	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—sarcoma	5.29e-06	0.000387	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—sarcoma	5.25e-06	0.000384	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLCG1—sarcoma	5.04e-06	0.000369	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—sarcoma	5.02e-06	0.000367	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—sarcoma	4.74e-06	0.000347	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—sarcoma	4.68e-06	0.000342	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—sarcoma	4.62e-06	0.000338	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—sarcoma	4.56e-06	0.000334	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—sarcoma	4.25e-06	0.000311	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—sarcoma	4.16e-06	0.000304	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—sarcoma	3.93e-06	0.000287	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—sarcoma	3.49e-06	0.000255	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—sarcoma	3.34e-06	0.000244	CbGpPWpGaD
